131 related articles for article (PubMed ID: 32596388)
1. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.
Ma Q; Wang X; Wang H; Song W; Wang Q; Wang J
Biomed Res Int; 2020; 2020():8610271. PubMed ID: 32596388
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.
Zhang XY; Guo ZQ; Ji SQ; Zhang M; Jiang N; Li XS; Zhou LQ
Asian J Androl; 2012 May; 14(3):487-92. PubMed ID: 22504871
[TBL] [Abstract][Full Text] [Related]
4. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
5. HMGN5: a potential oncogene in gliomas.
Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
[TBL] [Abstract][Full Text] [Related]
6. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
He J; Liu C; Wang B; Li N; Zuo G; Gao D
Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299
[TBL] [Abstract][Full Text] [Related]
7. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.
Chen P; Wang XL; Ma ZS; Xu Z; Jia B; Ren J; Hu YX; Zhang QH; Ma TG; Yan BD; Yan QZ; Li YL; Li Z; Yu JY; Gao R; Fan N; Li B; Yang JL
Asian Pac J Cancer Prev; 2012; 13(7):3223-8. PubMed ID: 22994738
[TBL] [Abstract][Full Text] [Related]
9. The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.
Weng M; Song F; Chen J; Wu J; Qin J; Jin T; Xu J
Tumour Biol; 2015 Feb; 36(2):959-66. PubMed ID: 25315189
[TBL] [Abstract][Full Text] [Related]
10. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.
Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303
[TBL] [Abstract][Full Text] [Related]
11. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
12. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
[TBL] [Abstract][Full Text] [Related]
13. Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein.
Malicet C; Rochman M; Postnikov Y; Bustin M
Mol Cell Biol; 2011 Jul; 31(13):2742-55. PubMed ID: 21518955
[TBL] [Abstract][Full Text] [Related]
14. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.
Zhou X; Yuan B; Yuan W; Wang C; Gao R; Wang J
Tumour Biol; 2014 Jul; 35(7):6539-47. PubMed ID: 24687550
[TBL] [Abstract][Full Text] [Related]
15. Research advances in HMGN5 and cancer.
Shi Z; Tang R; Wu D; Sun X
Tumour Biol; 2016 Feb; 37(2):1531-9. PubMed ID: 26700674
[TBL] [Abstract][Full Text] [Related]
16. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
[TBL] [Abstract][Full Text] [Related]
17. UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313.
Shao L; He Q; Liu Y; Liu X; Zheng J; Ma J; Liu L; Li H; Li Z; Xue Y
Cell Death Dis; 2019 Aug; 10(9):629. PubMed ID: 31427569
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.
Jiang W; Zheng J; Yu T; Wang J
Oncol Rep; 2017 Aug; 38(2):1099-1107. PubMed ID: 28627703
[TBL] [Abstract][Full Text] [Related]
19. HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis.
Mou J; Huang M; Wang F; Xu X; Xie H; Lu H; Li M; Li Y; Kong W; Chen J; Xiao Y; Chen Y; Wang C; Ren J
Mol Cancer Res; 2022 Dec; 20(12):1724-1738. PubMed ID: 36066963
[TBL] [Abstract][Full Text] [Related]
20. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
